The Anti-Tumor Efficacy of 3C23K, a Glyco-Engineered Humanized Anti-Misrii Antibody, in an Ovarian Cancer Model Is Mainly Mediated by Engagement of Immune Effector Cells
Oncotarget - United States
doi 10.18632/oncotarget.15715
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 25, 2017
Authors
Publisher
Impact Journals, LLC